Preclinical development of humanized CD39 and CD73 blocking antibodies targeting the ATP/adenosine immune checkpoint pathway for cancer immunotherapy

被引:3
|
作者
Perrot, Ivan [1 ]
Paoli, Marc Giraudon [1 ]
Augier, Severine [1 ]
Blemont, Marilyne Royannez [1 ]
Gaudin, Marion [1 ]
Bosco, Frederic [1 ]
Courtois, Rachel [1 ]
Delahaye, Stephane [1 ]
Jecko, Diana [1 ]
Gourdin, Nicolas [1 ]
Agu, Maryline Salin [1 ]
Perrier, Cyril [1 ]
Ricaut, Paul [1 ]
Docquier, Aurelie [2 ]
Chanteux, Stephanie [1 ]
Rossi, Benjamin [1 ]
Represa, Agnes [1 ]
Denis, Caroline [1 ]
Remark, Romain [1 ]
Bonnafous, Cecile [1 ]
Gauthier, Laurent [1 ]
Morel, Ariane [1 ]
Bonnefoy, Nathalie [2 ]
Bastid, Jeremy [2 ]
Morel, Yannis [1 ]
Paturel, Carine [1 ]
机构
[1] Innate Pharma, Marseille, France
[2] Orega Biotech, Ecully, France
关键词
D O I
10.1158/1538-7445.AM2018-2718
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2718
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Preclinical development of a humanized blocking antibody targeting the CD39 immune checkpoint for cancer immunotherapy
    Augier, Severine
    Perrot, Ivan
    Dejou, Cecile
    Joly, Rachel
    Delahaye, Stephane
    Blanc, Helene Rispaud
    Denis, Caroline
    Gauthier, Laurent
    Bensussan, Armand
    Eliaou, Jean-francois
    Morel, Yannis
    Bonnefoy, Nathalie
    Bastid, Jeremy
    Paturel, Carine
    [J]. CANCER RESEARCH, 2016, 76
  • [2] Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
    Perrot, Ivan
    Michaud, Henri-Alexandre
    Giraudon-Paoli, Marc
    Augier, Severine
    Docquier, Aurelie
    Gros, Laurent
    Courtois, Rachel
    Dejou, Cecile
    Jecko, Diana
    Becquart, Ondine
    Rispaud-Blanc, Helene
    Gauthier, Laurent
    Rossi, Benjamin
    Chanteux, Stephanie
    Gourdin, Nicolas
    Amigues, Beatrice
    Roussel, Alain
    Bensussan, Armand
    Eliaou, Jean-Francois
    Bastid, Jeremy
    Romagne, Francois
    Morel, Yannis
    Narni-Mancinelli, Emilie
    Vivier, Eric
    Paturel, Carine
    Bonnefoy, Nathalie
    [J]. CELL REPORTS, 2019, 27 (08): : 2411 - +
  • [3] CD39/CD73/A2AR pathway and cancer immunotherapy
    Xia, Chenglai
    Yin, Shuanghong
    To, Kenneth K. W.
    Fu, Liwu
    [J]. MOLECULAR CANCER, 2023, 22 (01)
  • [4] CD39/CD73/A2AR pathway and cancer immunotherapy
    Chenglai Xia
    Shuanghong Yin
    Kenneth K. W. To
    Liwu Fu
    [J]. Molecular Cancer, 22
  • [5] Discovery and characterization of new original blocking antibodies targeting the CD73 immune checkpoint for cancer immunotherapy
    Paoli, Marc Giraudon
    Augier, Severine
    Blemont, Marilyne Royannez
    Rodriguez, Celine
    Blanc, Helene Rispaud
    Chanteux, Stephanie
    Gourdin, Nicolas
    Gauthier, Laurent
    Caux, Christine Menetrier
    Morel, Yannis
    Caux, Christophe
    Paturel, Carine
    Perrot, Ivan
    [J]. CANCER RESEARCH, 2016, 76
  • [6] A new generation of immunotherapies targeting the CD39 / CD73 / adenosine pathway to promote the anti-tumor immune response
    Gros, Laurent
    Paturel, Carine
    Perrot, Ivan
    Bensussan, Armand
    Eliaou, Jean-Francois
    Bastid, Jeremy
    Bonnefoy, Nathalie
    [J]. M S-MEDECINE SCIENCES, 2020, 36 (02): : 112 - +
  • [7] The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition
    Bauer, Arthur
    Gebauer, Niklas
    Knief, Juliana
    Tharun, Lars
    Arnold, Nele
    Riecke, Armin
    Steinestel, Konrad
    Witte, Hanno M.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3193 - 3208
  • [8] The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition
    Arthur Bauer
    Niklas Gebauer
    Juliana Knief
    Lars Tharun
    Nele Arnold
    Armin Riecke
    Konrad Steinestel
    Hanno M. Witte
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3193 - 3208
  • [9] IPH5301, a CD73 blocking antibody targeting the adenosine immunosuppressive pathway for cancer immunotherapy
    Perrot, Ivan
    Denis, Caroline
    Giraudon-Paoli, Marc
    Augier, Severine
    Courtois, Rachel
    Jecko, Diana
    Breso, Violette
    Arnoux, Thomas
    Gourdin, Nicolas
    Remark, Romain
    Bonnafous, Cecile
    Morel, Ariane
    Vivier, Eric
    Morel, Yannis
    Andre, Pascale
    Paturel, Carine
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [10] CD39 and CD73: targets for immune regulation by moxibustion
    Wu, Qiaofeng
    [J]. PURINERGIC SIGNALLING, 2018, 14 : S73 - S73